Common Contracts
3 similar Exclusive Sublicense Agreement contracts by Asterias Biotherapeutics, Inc., Biotime Inc
EXCLUSIVE SUBLICENSE AGREEMENT Between GERON CORPORATION and ASTERIAS BIOTHERAPEUTICS, INC.Exclusive Sublicense Agreement • November 12th, 2013 • Biotime Inc • Biological products, (no disgnostic substances) • California
This EXCLUSIVE SUBLICENSE AGREEMENT (the “Agreement”) is entered into as of October 1, 2013 (the “Effective Date”) by and between Geron Corporation, a Delaware corporation having a principal place of business at 149 Commonwealth Drive, Menlo Park, California 94025 (“Geron”), and Asterias Biotherapeutics, Inc., a Delaware corporation having a principal place of business at 1301 Harbor Bay Parkway, Alameda, CA 94502 (“Licensee”). Geron and Licensee are each referred to individually herein as a “Party,” and collectively as the “Parties.”
EXCLUSIVE SUBLICENSE AGREEMENT between GERON CORPORATION and ASTERIAS BIOTHERAPEUTICS, INC.Exclusive Sublicense Agreement • November 12th, 2013 • Asterias Biotherapeutics, Inc. • Biological products, (no disgnostic substances) • California
This EXCLUSIVE SUBLICENSE AGREEMENT (the “Agreement”) is entered into as of October 1, 2013 (the “Effective Date”) by and between Geron Corporation, a Delaware corporation having a principal place of business at 149 Commonwealth Drive, Menlo Park, California 94025 (“Geron”), and Asterias Biotherapeutics, Inc., a Delaware corporation having a principal place of business at 1301 Harbor Bay Parkway, Alameda, CA 94502 (“Licensee”). Geron and Licensee are each referred to individually herein as a “Party,” and collectively as the “Parties.”
EXCLUSIVE SUBLICENSE AGREEMENT between GERON CORPORATION and BIOTIME ACQUISITION CORPORATIONExclusive Sublicense Agreement • August 13th, 2013 • Asterias Biotherapeutics, Inc. • Biological products, (no disgnostic substances) • California
This EXCLUSIVE SUBLICENSE AGREEMENT (the “Agreement”) is entered into as of _____________, 2013 (the “Effective Date”) by and between Geron Corporation, a Delaware corporation having a principal place of business at 149 Commonwealth Drive, Menlo Park, California 94025 (“Geron”), and BioTime Acquisition Corporation, a Delaware corporation having a principal place of business at 1301 Harbor Bay Parkway, Alameda, CA 94502 (“Licensee”). Geron and Licensee are each referred to individually herein as a “Party,” and collectively as the “Parties.”
